hmpl-689
Small moleculeexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 23, 2016 (NCT02631642)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hmpl-689
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05713110 | Phase 2 | Feb 13, 2023 | Hutchison MediPharma, University of Washington |
| NCT04849351 | Phase 2 | Apr 14, 2021 | Fudan University, Hutchison MediPharma, Sun Yat-Sen University |
| NCT03786926 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2019 | Hutchison MediPharma |
| NCT03128164 | Phase 1 | Jul 31, 2017 | Hutchison MediPharma |
| NCT02631642 | Phase 1 | Mar 23, 2016 | Hutchison MediPharma, Nucleus Network Ltd |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hutchison MediPharma | For profit | 5 | 4 | 2 | 2016 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2016 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2023 |
5 organizations
Page 1 / 1